Skip to main content

Advertisement

SpringerLink
Log in

Mechanisms of Improved Outcomes for Breast Cancer between Surgical Oncologists and General Surgeons

  • Healthcare Policy and Outcomes
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Prior multi-institutional studies have reported a survival benefit of breast cancer treatment by surgical oncologists (SO) over general surgeons (GS).

Methods

Retrospective review tumor registry data of all breast cancer patients receiving primary treatment at a single institution from January 1, 1995, to December 31, 2008.

Results

During the time period, there were 2192 patients who received primary breast cancer treatment at this institution. The mean age was 57 years and the mean follow-up was >55 months. Stage distribution was similar between GS and SO. Overall survival (SO 83.8% vs. GS 75.6%) and disease-free survival (SO 80.7% vs. GS 72.0%) was highly statistically significant (P < 0.0001). For stages 1, 2a, 2b, 3a, and 3b there were statistically significant (P < 0.05) differences for overall and disease-free survival. Overall, the use of breast conservation was more likely by SO—52.6 vs. 38.3% all stages and 65.8 vs. 54.0% for stage 0–2. The compliance with all systemic therapies (chemotherapy and hormone therapy) was more likely if being treated by SO—77.3 vs. 68.5% (P < 0.02). The use of radiotherapy for breast conservation and in stage 3 mastectomy patients was higher for SO (P < 0.001). Participation in clinical trials was far higher for SO patients—56.2 vs. GS 7.0% (P < 0.001).

Conclusions

The value added by having primary breast cancer treatment by a SO seems to arise from the more successful completion of multidisciplinary care in a timely fashion and higher rates of clinical trial involvement.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Skinner KA, Helsper JT, Deapen D, Ye W, Sposto R. Breast cancer: do specialists make a difference? Ann Surg Oncol. 2003;10:606–15.

    Article  PubMed  Google Scholar 

  2. Scharl A, Göhring UJ. Does center volume correlate with survival from breast cancer? Breast Care (Basel). 2009;4:237–44.

    Article  Google Scholar 

  3. Katz SJ, Hofer TP, Hawley S, et al. Patterns and correlates of patient referral to surgeons for treatment of breast cancer. J Clin Oncol. 2007;25:271–6.

    Article  PubMed  Google Scholar 

  4. Nattinger AB, Laud PW, Sparapani RA, et al. Exploring the surgeon volume outcome relationship among women with breast cancer. Arch Intern Med. 2007;167:1958–63.

    Article  PubMed  Google Scholar 

  5. Kingsmore D, Hole D, Gillis C. Why does specialist treatment of breast cancer improve survival? The role of surgical management. Br J Cancer. 2004;90:1920–5.

    Article  PubMed  CAS  Google Scholar 

  6. Hillner BE, Smith TJ, Desch CE. Hospital and physician volume or specialization and outcomes in cancer treatment: importance in quality of cancer care. J Clin Oncol. 2000;18:2327–40.

    PubMed  CAS  Google Scholar 

  7. Chen CS, Liu TC, Lin HC, Lien YC. Does high surgeon and hospital surgical volume raise the five-year survival rate for breast cancer? A population-based study. Breast Cancer Res Treat. 2008;110:349–56.

    Article  PubMed  Google Scholar 

  8. Sariego J. The impact of facility volume/size on breast cancer treatment and outcome. Am Surg. 2010;76:1333–7.

    PubMed  Google Scholar 

  9. Waljee JF, Hawley S, Alderman AK, Morrow M, Katz SJ. Patient satisfaction with treatment of breast cancer: does surgeon specialization matter? J Clin Oncol. 2007;25:3694–8.

    Article  PubMed  Google Scholar 

  10. Hershman DL, Buono D, McBride RB, et al. Surgeon characteristics and receipt of adjuvant radiotherapy in women with breast cancer. J Natl Cancer Inst. 2008;100:199–206.

    Article  PubMed  Google Scholar 

  11. Zork NM, Komenaka IK, Pennington RE Jr, et al. The effect of dedicated breast surgeons on the short-term outcomes in breast cancer. Ann Surg. 2008;248:280–5.

    Article  PubMed  Google Scholar 

  12. Hawley ST, Hofer TP, Janz NK, et al. Correlates of between-surgeon variation in breast cancer treatments. Med Care. 2006;44:609–16.

    Article  PubMed  Google Scholar 

  13. Commission on Cancer. Cancer program standards, 2009. Rev. ed. Chicago: American College of Surgeons; 2009.

  14. Beatty JD, Rees J, Atwood M, Pugliese M, Bolejack V. Standardized evaluation of regional and institutional breast cancer outcomes. Am J Surg. 2008;195:636–40.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. OU Breast Institute, University of Oklahoma, Oklahoma City, OK, USA

    William C. Dooley MD, Jinju Bong MD & Jeanene Parker PA-C

Authors
  1. William C. Dooley MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jinju Bong MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jeanene Parker PA-C
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to William C. Dooley MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dooley, W.C., Bong, J. & Parker, J. Mechanisms of Improved Outcomes for Breast Cancer between Surgical Oncologists and General Surgeons. Ann Surg Oncol 18, 3248–3251 (2011). https://doi.org/10.1245/s10434-011-1771-7

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-011-1771-7

Keywords

Search

Navigation